Vishnu Chemicals Ltd Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Vishnu Chemicals Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Vishnu Chemicals Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Vishnu Chemicals Ltd — get its next earnings analysis in your feed
How does Vishnu Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Vishnu Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Vishnu Chemicals Ltd against every Chemicals & Petrochemicals company (Q2 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Vishnu Chemicals Ltd's management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Paushak Ltd (Q2 FY27)
Year-on-year increase in quarterly revenue: Rs 3,054 lakhs (approximately 52% growth) . Key results statement takeaways from Paushak Ltd's Q2 FY27 results state
- Platinum Industries Ltd (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- Galaxy Surfactants Ltd (Q2 FY26)
Capital Work-in-Progress (CWIP) was around INR 260 crores as of FY '25. Key concall takeaways from Galaxy Surfactants Ltd's Q2 FY26 earnings call — and how it…
- Neogen Chemicals Ltd (Q2 FY26)
Neogen Chemicals rebuilding plant with potential incremental capex post insurance evaluation, mostly double-digit crores, no large capex planned next 1-2…